Department of Defence Tender by Dg Armed Forces Medical Service (21d19698a)

ACYCLOVIR 5 PERCENT OINT,AMINO ACID PREPARATION IV BOTT OF 200 TO 250 ML,BACLOFEN 10 MG TAB,BISOPRO

Goods
Qty:3.6L

Tender Timeline

Tender Issue
May 29, 2025 at 10:19 AM

Title: Medicine Demand ECHS RE 11

Reference Number: 21d19698a

Issuing Authority:

The tender is issued by the Department of Defence, under the Ministry of Defence.

Scope of Work and Objectives:

The purpose of this tender is to procure a range of essential medicines required for the Ecosystem of the Command Hospital. The products include a variety of pharmaceutical items, specifically:

  • ACYCLOVIR 5 PERCENT OINT
  • AMINO ACID PREPARATION IV BOTT OF 200 TO 250 ML
  • BACLOFEN 10 MG TAB
  • BISOPROLOL 2.5 MG TAB
  • Additional medicines such as DUTASTERIDE, VENLAFAXINE, SITAGLIPTIN, among others totaling 360,314 units.

The objective is to meet the demand of military and civilian healthcare systems by ensuring the availability of these critical medications.

Eligibility Criteria:

To be eligible for participation in this tender, bidders must meet the following requirements:

  • Be a registered entity with a valid license to manufacture or supply pharmaceuticals.
  • Hold necessary certificates attesting to the safety and efficacy of the medications proposed.
  • Comply with all regulatory requirements as dictated by pharmaceutical authorities.

Technical Requirements:

Bidders should provide detailed specifications for each item they intend to supply, including:

  • Quality standards and certifications relevant to pharmaceutical products.
  • Compliance with applicable health and safety regulations.
  • Testing criteria to demonstrate the safety and quality of medicines supplied.

Financial Requirements:

Bidders must ensure they have the financial capability to fulfill the tender requirements. This includes:

  • Submission of the Earnest Money Deposit (EMD) as specified in the tender documents.
  • Providing performance security after award of contract to ensure compliance with contractual obligations.

Document Submission Details:

Interested bidders are required to submit their proposals through the prescribed formats available with the tender documentation. This includes technical bids, financial proposals, and any other necessary certification documents as specified.

Special Provisions:

This tender encourages Micro, Small and Medium Enterprises (MSEs) and startups to participate, providing benefits such as:

  • Relaxed eligibility criteria.
  • Possible preferences in the bidding process to promote local suppliers.

Evaluation Process:

Bids will be evaluated based on:

  • Technical compliance with the specifications required.
  • Financial proposals in relation to pricing and value for money.
  • The evaluation committee will assess the bids to ensure they meet all stipulated requirements.

Delivery Locations:

The successful bidder will be responsible for delivering the medicines to designated military hospitals as specified in the tender documentation.

Contact Information:

Specific contact details for inquiries and clarifications are included in the tender document. Bidders are encouraged to reach out directly for any additional information required.


Tender BOQ Items

30 Items
1.

ACYCLOVIR 5 PERCENT OINT

Qty:30
Unit:tube
30
2.

AMINO ACID PREPARATION IV BOTT OF 200 TO 250 ML

Qty:14
Unit:bott
30
3.

BACLOFEN 10 MG TAB

Qty:12300
Unit:no
30
4.

BISOPROLOL 2 POINT 5 MG TAB

Qty:13200
Unit:no
30
5.

CARBIDOPA 25 MG AND LEVODOPA 100 MG CR TAB SYNDOPA CR 125 MG

Qty:19200
Unit:no
30
6.

CHLORHEXIDINE MOUTH WASH 2 PERCENTAGE BOTT OF 100 ML

Qty:1600
Unit:bott
30
7.

CLONIDINE 100 MCG TAB

Qty:6200
Unit:no
30
8.

CYCLOSPORIN 50 MG TAB

Qty:180
Unit:no
30
9.

DIVALPROEX 500 MG TAB

Qty:7300
Unit:no
30
10.

DUTASTERIDE 0 POINT 5 MG TAB

Qty:19500
Unit:no
30
11.

ENTECAVIR 0 POINT 5 MG TAB

Qty:800
Unit:no
30
12.

EZETIMIBE 10 MG TAB

Qty:1500
Unit:no
30
13.

GINKGO BILOBA TAB

Qty:1800
Unit:no
30
14.

HYDROCHLOROTHIAZIDE 12 POINT 5 MG TAB

Qty:36000
Unit:no
30
15.

INJ GLULISINE CART INJECTION 100IU PER ML APIDRA 3 ML

Qty:30
Unit:cart
30
16.

NANDROLONE DECONATE 50 MG INJ

Qty:3000
Unit:no
30
17.

LETROZOLE 2 POINT 5MG TAB

Qty:3600
Unit:no
30
18.

LULICONAZOLE CREAM

Qty:300
Unit:tube
30
19.

MIRABEGRON 50 MG TAB

Qty:19200
Unit:no
30
20.

NEPAFENAC 0 POINT 3 PERCENT W PER V 5 ML ED

Qty:900
Unit:bott
30
21.

ORAL TEETHING SOL ZYTEE MOUTH LOTION 10ML

Qty:540
Unit:bott
30
22.

PERMETHRIN 5 PERCET W PER W TUBE OF 30 GM

Qty:70
Unit:tube
30
23.

QUETIAPINE 50 MG TAB

Qty:4800
Unit:no
30
24.

ROPINIROLE 0 POINT 5 MG TAB

Qty:6600
Unit:no
30
25.

SOLIFENACIN 5 MG TAB

Qty:5150
Unit:no
30
26.

SYP CYPROHEPTADINE 2MG OR 5 MG BOTT OF 100 ML

Qty:2100
Unit:bott
30
27.

TORSEMIDE 100 MG TAB

Qty:3600
Unit:no
30
28.

VENLAFAXINE 37 POINT 5 MG TAB

Qty:1800
Unit:no
30
29.

SITAGLIPTIN 50 MG TAB

Qty:69000
Unit:no
30
30.

TAMSULIN 0 POINT 4 MG AND DUTASTERIDE 0 POINT 5 MG TAB

Qty:120000
Unit:no
30

General Information

Item Category
ACYCLOVIR 5 PERCENT OINT , AMINO ACID PREPARATION IV BOTT OF 200 TO 250 ML , BACLOFEN 10 MG TAB , BISOPROLOL 2 POINT 5 MG TAB , CARBIDOPA 25 MG AND LEVODOPA 100 MG CR TAB SYNDOPA CR 125 MG , CHLORHEXIDINE MOUTH WASH 2 PERCENTAGE BOTT OF 100 ML , CLONIDINE 100 MCG TAB , CYCLOSPORIN 50 MG TAB , DIVALPROEX 500 MG TAB , DUTASTERIDE 0 POINT 5 MG TAB , ENTECAVIR 0 POINT 5 MG TAB , EZETIMIBE 10 MG TAB , GINKGO BILOBA TAB , HYDROCHLOROTHIAZIDE 12 POINT 5 MG TAB , INJ GLULISINE CART INJECTION 100IU PER ML APIDRA 3 ML , NANDROLONE DECONATE 50 MG INJ , LETROZOLE 2 POINT 5MG TAB , LULICONAZOLE CREAM , MIRABEGRON 50 MG TAB , NEPAFENAC 0 POINT 3 PERCENT W PER V 5 ML ED , ORAL TEETHING SOL ZYTEE MOUTH LOTION 10ML , PERMETHRIN 5 PERCET W PER W TUBE OF 30 GM , QUETIAPINE 50 MG TAB , ROPINIROLE 0 POINT 5 MG TAB , SOLIFENACIN 5 MG TAB , SYP CYPROHEPTADINE 2MG OR 5 MG BOTT OF 100 ML , TORSEMIDE 100 MG TAB , VENLAFAXINE 37 POINT 5 MG TAB , SITAGLIPTIN 50 MG TAB , TAMSULIN 0 POINT 4 MG AND DUTASTERIDE 0 POINT 5 MG TAB
Ministry Name
Department Name

Financial Information

Bid Offer Validity
90 (Days)
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Total value wise evaluation
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

4 Documents
GeM-Bidding-7898772.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Similar Tenders

View All

Morphine 15 mg, 1 ml Inj,Pethedine 50 mg, 1 ml Inj,Tramadol HCl 50 mg Cap or Tab,Clonazepam 2 mg Ta

GEM
Goods
Qty:4.5L
4 Files
Indian Army
Boq › Boql
Morphine 15 mg, 1 ml Inj , Pethedine 50 mg, 1 ml Inj , Tramadol HCl 50 mg Cap or Tab , Clonazepam 2 mg Tab , Clotrimazole mouth paint 1 percent bottle of 15 ml , Tranexamic Acid 500 mg per 5ml Inj , Antiseptic mouth wash containing Sodium fluoride and triclosan bott of 100 ml , Benzocaine 20 percent, Pectin based, oral ointment Tube of 5 gm , Adapalene 0.1 percent Tube of 15 gm , Benzoyl Peroxide 2.5 percent Tube of 20 gm , Antispasmodic Tab containing Mefenamic Acid 250 mg and Dicyclomine HCl 10 mg , Metoclopramide syrup 5mg percent 5ml bott of 30 ml , Isapgol or Ispaghula husk 3.5 gm , Loperamide 2mg Tab , Gentamicin sulphate 0.3 percent w per v gentamicin base with Hydrocortisone acetate IP 1 percent w per v eye and ear drops bott of 5 ml , Cinnarizine 25 mg Tab , Clotrimazole 1 percent w per v IP plus Lignocaine 2 percent w per v IP ear drop, bott of 10ml , Nasal Decongestant adult drops, Xylometazoline HCl 0.1 percent w per v nasal drop bottle of 10 ml , Metronidazole susp 200 mg per 5ml bott of 60 ml , Alprazolam 0.25 mg Tab , Sterile water, amp of 10 ml , Anti phlebitis cream Tube of 15 g or 20 g , Glucosamine 500 mg Tab , Antacid chewable containing dried Aluminium Hydroxide IP 250 mg, Mag Hydroxide NF 250 mg, Methyl Polysiloxane 50 mg Tab , Hepatitis B Vaccine 10 ml , Glucose saline isotonic solution in non toxic disposable plastic bott of 500ml FFS , Adjustable arm pouch sling size L or M or S , Heel Cup, Silicon or Carbon Copolymer , Cough sedative syp, each 5 ml containingChlorpheniramine maleate 2.5mg, Guaiphenesin 100mg, Noscapine 15mg, Sodium citrate 60mg in flavoured base, bott of 100 ml
May 30, 2025
June 21, 2025 at 11:00 AM
View Details

Frequently Asked Questions

The eligibility requirements to participate in this tender include the necessity to be a registered entity with a valid pharmaceutical license, compliance with healthcare regulations, and possession of essential certifications related to the safety and efficacy of the drugs proposed. Companies should also be in good standing with the relevant authorities.

Bidders must provide necessary certificates attesting to the quality and safety of the pharmaceutical products offered. This includes Good Manufacturing Practice (GMP) certificates, product approvals from pharmaceutical regulatory bodies, and any other relevant documentation that ensures compliance with national health standards.

To register, bidders should follow the formal registration process outlined in the tender documents. This involves submitting a filled registration form along with the required certificates. All documents should be submitted in the prescribed formats, which usually include both digital and hard copy submissions, as specified in the tender invitation.

All medicines must adhere to stringent quality standards mandated by health authorities. Bidders are required to demonstrate compliance with such standards through appropriate testing and certification, ensuring that all products meet the expected safety and quality benchmarks for pharmaceutical products.

Yes, the tender contains specific provisions for Micro, Small, and Medium Enterprises (MSEs) to encourage their participation. MSEs may benefit from relaxed eligibility criteria and preferential treatment during the evaluation process to promote local industry and foster small business growth.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders